Generic medications could be an effective way to improve health outcomes while lowering costs, but the existing drug patent system is poorly designed to motivate such discoveries, says an expert on health law at Washington University in St. Louis.”Additional testing and approvals are common for expensive on-patent drugs, but we don’t often seek out new uses for less expensive generic drugs, since it can be more difficult to profit from the research,” said Rachel Sachs, associate professor of law…